Blog
As we move into 2020, the dynamics shaping biopharmaceutical decision-making are moving faster than ever. But constant change makes it difficult to focus and plan, showing that it’s all the more important to prepare for the future by keeping a trained eye on the major shifts … Read More »
Today, life science companies and research organizations face unique challenges related to clinical trial patient recruitment which often causes major delays and challenges for research across multiple disease states. Up to 90% of studies in the U.S. experience significant d … Read More »
As we move into 2020, the dynamics shaping biopharmaceutical decision-making are moving faster than ever. But constant change makes it difficult to focus and plan, showing that it’s all the more important to prepare for the future by keeping a trained eye on the major shifts … Read More »
This is Medidata’s first of a five-part blog series on the most important characteristics of a unified technology platform. Read about the other four characteristics in this blog series: collaboration, single-source of truth, security and privacy, and scalability. Did you kn … Read More »
Provisions of the US Food and Drug Administration’s 2016 21st Century Cures Act, and several initiatives funded by the European Medicines Agency, have greatly increased demand for real-world data (RWD) from life sciences companies. These initiatives have increased the potent … Read More »
Healthline Media provides credible health information that is distinguished by compassion for the human experience. Join Healthline Media, and support the modern consumer on their health and wellness journey. Learn more CAPABILITIES AND PARTNERSHIP Healthline Media’s adverti … Read More »
Evidera recently released an article about Pragmatic Randomized Trials. Read the full article: http://bit.ly/EvideraNov2019 Introduction The 21st Century Cures Act (Cures Act), which became law in the United States December 13, 2016, has highlighted the need for robust real- … Read More »
ICON recently released lots of valuable information about improving patient recruitment. Making it easier for the site and the patient to actively participate in a trial is an essential part of increasing predictability in enrolment and retention. ICON provides Site & Pa … Read More »
By Andrew Kusmierczyk, Scientist, CMC, Cardinal Health Regulatory Sciences Publication plans. Journal articles. Conference abstracts. Investigator brochures. INDs. NDAs. BLAs. MSL slide decks. Scientific platforms. Educational materials for HCPs. Talk tracks. Visual Aids. Pa … Read More »
Nearly 80% of clinical trials fail to meet their activation timelines. But why does the start-up process fail us this often? This question can be answered by implementing a Feasibility Maturity Model with six critical variables. Understand the 6 key variables: bit.ly/2IORt0c
The aim of this article is to discuss the current use of real-world data and evidence in health technology assessment (HTA) and payer appraisals, its potential role in lifecycle management, and how the early dialogue provided by Integrated Scientific Advice (ISA) engagement … Read More »
This month’s SpeakOut sets its sites on real-world data as a driver of outcomes. Joe Jackson, SVP Operations at EngagedMedia, takes a look at how mobile devices and patient-generated data influence the overall care plan, and how pharma marketers can utilize the data for stra … Read More »
October 21-22, 2019 in Washington, D.C. The Rare Summit affords an unprecedented opportunity to hear from the experts, including the heads of the three FDA medical centers, and join conversations of the pressing issues facing the rare disease community, including addressing … Read More »
Register today for our day-long #patientadvocacy forum on Oct 23 in Washington, DC! We’ll bring together Patient Advocacy Groups, patients, and drug developers to discuss ways to make real change that increase the value to patients in clinical research. bit.ly/2m2VsOb
By: Vincent Marino, Director of Strategic Partnerships, SHYFT Analytics The last decade has seen an explosion in the volume of patient-level data available to companies marketing specialty therapies. Drug manufacturers and industry business partners have responded by buildin … Read More »
Given the rapid changes in #clinicalresearch, it can be challenging for sites to thrive & event grow. In this conference, we will focus on how to differentiate your site for success. Join WCG on Oct 7 in Philadelphia, PA to learn more: bit.ly/2kuisoZ
There’s an entirely new way to listen to patients, enabling researchers to better understand the patient experience by capturing authentic stories and translating sound science into actionable insights. This structured methodology combined with sociolinguistic analysis and A … Read More »
In April 2019, members of Evidera’s Policy Trends team had the opportunity to speak with scientific staff members from the Canadian Agency for Drugs and Technologies in Health (CADTH) to discuss new opportunities available through CADTH’s scientific advice services. Read the … Read More »
This post contains excerpts from the June 2019 cover article in PharmaVOICE Magazine, written by Robin Robinson. Cognizant has been using AR technology at clinical congresses for several years, says Bryan Hill, chief technology officer, life sciences, Cognizant. One particul … Read More »
In the June Speak OUT feature in PharmaVOICE Magazine, Larissa Comis of Cognizant describes how the Cognizant Shared Investigator Platform is a disruptive innovation that can help companies achieve positive outcomes. Best Practices for Adopting the Shared Investigator Platfo … Read More »
